bpc 157 ulcerative colitis phase ii trial Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions Stable gastric pentadecapeptide BPC 157
Description
Eflornithine is a topical medication formulated at 13.9% strength
Documented research protocols reference a figure of approximately 50 mg per administration
doi: 10.1016/S1474-4422(07)70104-7 Pubmed Abstract CrossRef Google Scholar View reference in article 30 AlpertJEMischoulonDNierenbergAAFavaM
PMC 2809139
